Antibiotics and Probiotics in Inflammatory Bowel Disease: Why, When, and How

Cosimo Prantera; Maria Lia Scribano

Curr Opin Gastroenterol. 2009;25(4):329-333.

NOD2/CARD15 and Resistance to Antibiotics

One important question concerning antibiotics and Crohn's disease is their ineffectiveness in about 40–50% of patients. An interesting light on this problem has been shed by a study on the relationship between antibiotic response and NOD2/CARD15 gene variants. Cipro was dispensed to 49 and metro to 3 patients with perianal disease.^[23•] A complete fistula response was recorded in 33.3% of patients with NOD2/CARD15 wild type compared with none of those with NOD2/CARD15 variants. This result could indicate that more than one reason is at the origin of the failure of antibiotics, apart from the bacteria resistance and low patient compliance. Unfortunately, neither Bacteroides nor Enterobacteriaceae group was permanently suppressed by metro-cipro therapy and they tended to reappear when the treatment was stopped.^[24•]

1 2 3 4 5 6 7 8

Next Section

Cite this: Antibiotics and Probiotics in Inflammatory Bowel Disease: Why, When, and How - Medscape - Jul 01, 2009.

Abstract and Introduction
Antimycobacterial Therapy and Crohn's Disease
Antibiotics and Crohn's Disease
NOD2/CARD15 and Resistance to Antibiotics
Antibiotics and Ulcerative Colitis
Clostridium Difficile Infection and Inflammatory Bowel Disease
Probiotics
Conclusion
References

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.